Cannabis, schizophrenia, genomics and the complexity of disease

Molecular Psychiatry advance online publication 24 June 2014; doi: 10.1038/mp.2014.51

Genetic predisposition to schizophrenia associated with increased use of cannabis

R A Power^1,2, K J H Verweij³, M Zuhair¹, G W Montgomery⁴, A K Henders⁴, A C Heath⁵, P A F Madden⁵, S E Medland⁴, N R Wray² and N G Martin⁴

1. ¹MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, UK
2. ²Queensland Brain Institute, The University of Queensland, St Lucia, QLD, Australia
3. ³Department of Developmental Psychology and EMGO Institute for Health and Care Research, VU University, Amsterdam, The Netherlands
4. ⁴QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
5. ⁵Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA

Correspondence: R Power, MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, DeCrespigny Park, Denmark Hill, London SE5 8AF, UK. E-mail: robert.r.power@kcl.ac.uk

http://www.nature.com/mp/journal/vaop/ncurrent/abs/mp201451a.html